PCOS has been renamed to PMOS (Polyendocrine Metabolic Ovarian Syndrome) to better reflect that this is a whole-body metabolic condition — not just an ovarian cyst problem. Your diagnosis is still valid, your treatment doesn't change, and you don't need to be re-tested. The Rotterdam diagnostic criteria remain the same.
Why Did PCOS Get Renamed?
The name "Polycystic Ovary Syndrome" was coined in 1935. It described what doctors saw on ultrasound — small follicles on the ovaries that looked like cysts. But here's what decades of research have made clear: those "cysts" aren't actually cysts, many women with PCOS don't even have them, and the ovaries are only part of a much larger metabolic picture.
On May 12, 2026, a landmark paper published in The Lancet formalized what researchers had been advocating for years. The international panel — representing 22,000 healthcare professionals and 56 medical organizations — settled on PMOS: Polyendocrine Metabolic Ovarian Syndrome.
Poly = multiple systems involved. Endocrine = it's a hormonal condition. Metabolic = insulin resistance is central. Ovarian = it does affect the ovaries. Syndrome = it's a cluster of symptoms, not a single disease. Every word earns its place.
The old name caused real harm. Women who didn't have visible ovarian cysts were told they "didn't have PCOS." Women who did have cysts were told it was an ovarian problem when the real driver was insulin resistance, inflammation, or adrenal androgens. The name change reflects where the science actually is — not where it was in 1935.
What Changes (and What Doesn't)
| What Stays the Same | What Changes |
|---|---|
| Rotterdam diagnostic criteria (2 of 3: irregular periods, hyperandrogenism, polycystic ovaries) | The name — PCOS becomes PMOS on all new medical documents |
| First-line treatments (letrozole for ovulation, metformin for insulin resistance) | Medical education — metabolic screening now standard at diagnosis |
| Your existing diagnosis — no re-diagnosis needed | Insurance coding — ICD codes will update over 12-24 months |
| Lifestyle recommendations (exercise, nutrition, stress management) | Awareness — 70% of undiagnosed women may now get flagged through metabolic screening |
| Supplement protocols (inositol, NAC, vitamin D) | Stigma — removing "polycystic" helps end the "it's just a cosmetic issue" dismissal |
The Numbers Behind the Rename
That 70% figure is staggering. It means roughly 119 million women worldwide have PMOS and don't know it. Many have been told their irregular periods are "just stress," their weight gain is a personal failing, or their acne is "hormonal but normal." The rename comes with a push for routine metabolic screening — which could finally change those numbers.
A Quick History of How We Got Here
1935 — Stein and Leventhal
Two doctors describe a syndrome of irregular periods, excess hair growth, and enlarged ovaries with multiple "cysts." They call it Stein-Leventhal Syndrome.
1990 — NIH Criteria
The first official diagnostic criteria are published. They require both irregular ovulation and hyperandrogenism — but don't require ovarian cysts.
2003 — Rotterdam Criteria
The criteria expand to a "2 of 3" model: irregular periods, excess androgens, or polycystic ovaries on ultrasound. This is still the diagnostic standard today.
2018-2023 — Rename Advocacy Grows
International guidelines from ACOG, the Endocrine Society, and patient advocacy groups call the name misleading. "Polycystic" implies cysts that aren't actually cysts.
May 12, 2026 — PMOS Is Born
The Lancet publishes the consensus paper. 22,000 experts, 56 organizations endorse the rename to Polyendocrine Metabolic Ovarian Syndrome.
What This Means for Your Fertility
If you're trying to conceive with a PCOS/PMOS diagnosis, the practical takeaways are reassuring: the treatments that work haven't changed. What has changed is how the medical community understands why they work.
Ovulation Induction
Letrozole remains the first-line ovulation induction medication, replacing clomiphene citrate (Clomid) at the top of the treatment ladder per ACOG's current guidelines. If you're not ovulating, this is still where your doctor will start. For a deeper dive into the evidence, see our letrozole vs. Clomid comparison.
Insulin Resistance
The PMOS framing puts insulin resistance front and center — which is exactly where it belongs. Up to 80% of women with PMOS have some degree of insulin resistance, and addressing it with metformin, inositol, or dietary changes can restore ovulation on its own in some cases. Our spoke site LifeFertile has a full PMOS supplement protocol covering the evidence-based stack.
The Metabolic Screening Shift
Perhaps the biggest fertility-relevant change: the rename comes with a recommendation that all PMOS patients receive metabolic screening at diagnosis. That means fasting glucose, fasting insulin, HbA1c, and a lipid panel — tests that many women with "PCOS" never received. Catching insulin resistance early means earlier intervention, which means better odds of conceiving without escalating to expensive treatments.
Weight and Fertility: The Nuance
One of the most damaging legacies of the "PCOS" era was the conflation of weight with the condition itself. Not all women with PMOS are overweight — about 20-30% have what's called "lean PMOS." And for those who do carry extra weight, the metabolic framing means the conversation shifts from "lose weight to fix your ovaries" to "address insulin resistance, which may naturally regulate your weight and your cycles."
Do You Need to Do Anything Right Now?
If you have an existing PCOS diagnosis: No immediate action is needed. Your diagnosis carries forward automatically. Here's what you might consider over the coming months:
- Ask about metabolic screening if you haven't had fasting insulin and glucose checked recently. The new guidelines recommend this for all PMOS patients.
- Update your language when talking to new providers. "I have PMOS, formerly known as PCOS" helps everyone stay on the same page during the transition.
- Review your supplement stack. If you're taking inositol, NAC, or vitamin D for PCOS, keep going — the evidence base is even stronger under the PMOS framework. See our full guide on supplements for PMOS.
- Don't panic about insurance. ICD codes will update over the next 12-24 months, but your coverage for treatment shouldn't be interrupted. If a claim is denied due to coding confusion, ask your billing department to reference the Lancet transition paper.
What About "Lean PCOS" — Is It Now "Lean PMOS"?
Yes, and the rename actually helps this subgroup the most. Women with lean PCOS have historically been the most under-diagnosed because they don't fit the stereotypical picture. They're not overweight, their ultrasounds may look normal, and their doctors often dismiss their irregular periods as "just how your body works."
Under the PMOS framework, the metabolic component gets screened regardless of weight. A woman with a BMI of 22 who has irregular cycles and elevated androgens should get the same fasting insulin test as a woman with a BMI of 35. That's a meaningful shift in how this condition is caught and treated.
How Other Conditions Relate to PMOS
PMOS doesn't exist in isolation. Women with this condition are at higher risk for several related conditions, and the metabolic-first framing makes those connections clearer:
- Thyroid disorders: Hashimoto's thyroiditis occurs at higher rates in women with PMOS. If you haven't had your thyroid checked, read our thyroid and fertility guide.
- Endometriosis: Some women have both PMOS and endometriosis. The symptoms overlap can make diagnosis tricky — see our PMOS vs. endometriosis comparison.
- Gestational diabetes: Women with PMOS are at 2-4x higher risk. Metabolic screening before conception can help you prepare.
- Cardiovascular disease: Long-term metabolic dysfunction increases cardiovascular risk. This is another reason why the rename matters — it flags lifelong health monitoring, not just fertility treatment.
Frequently Asked Questions
No. If you have an existing PCOS diagnosis using the Rotterdam criteria, your diagnosis automatically carries forward as PMOS. No new tests are required for the name change itself.
Yes. Insurance companies are transitioning ICD codes over the next 12-24 months. During the transition, both PCOS and PMOS codes will be accepted. If you encounter a billing issue, have your provider reference the Lancet transition paper.
Not necessarily. Letrozole for ovulation induction, metformin for insulin resistance, and lifestyle modifications remain the foundation of treatment. What may change is that your doctor now screens more thoroughly for metabolic markers like fasting insulin and HbA1c, which could lead to earlier or more targeted interventions.
Almost certainly not in the traditional sense. What shows up on ultrasound are actually immature follicles — tiny fluid-filled sacs that contain eggs but haven't fully developed. They're not harmful cysts that need removal. This is one of the main reasons the name was changed.
The transition will take time. Both terms will be used interchangeably for the foreseeable future. You don't need to correct anyone, but you can mention that you know about the rename if it feels relevant. What matters more than the name is whether your doctor is screening for metabolic markers and treating the full syndrome.
Yes. PMOS is one of the most treatable causes of infertility. Many women conceive with lifestyle changes and/or ovulation induction medication alone. For those who need more support, IUI and IVF are effective options. Our TTC with PMOS guide covers the full picture.
The most evidence-backed supplements for PMOS include myo-inositol + D-chiro-inositol (40:1 ratio), NAC (N-acetylcysteine), vitamin D, and berberine. See our complete PMOS supplement protocol for dosing, brand recommendations, and the research behind each one.
Read More Across Our Network
We've built comprehensive PMOS resources across all our sites, each tailored to a different stage of the journey:
Not Sure Where to Start?
Take our free fertility quiz to get personalized next steps based on your situation, age, and history.
Take the Free Quiz →Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. The PCOS to PMOS name change was published in The Lancet on May 12, 2026. Always consult with a qualified healthcare provider for personalized guidance regarding your diagnosis and treatment.